Completed Phase II and III clinical trials have indicated that the agent has a nonoverlapping toxicity profile and synergistic effects with carboplatin, paclitaxel, and anthracycline, has no cross-drug resistance and is well tolerated, with patients mostly reporting fatigue and nausea
Funding This work was supported by the Special Fund for Major Research Projects of Ningde Normal University (No
In red blood cells heterozygous carriers have an enzyme activity of about 50% of the normal mean and normal levels of glutathione [1]
"The Terminal"
Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 2017
The pharma has previously announced that REDEFINE 1 is expected to read out by the end of the year, while data from REDEFINE 2 are expected in the first half of 2025